Terms: = Prostate cancer AND EWSR1, EWS, 2130, ENSG00000182944
55 results:
1. Incidence and risk factors of prostate cancer among the Northern and Eastern parts of the United Arab Emirates population.
Al Shareef Z; Al-Shahrabi R; Saheb Sharif-Askari F; AlDhmanie A; Alshamsi Y; Zarooni AA; Mahmoud RA; Soliman SSM; Halwani R; Bendardaf R
Prostate; 2024 Feb; 84(2):185-192. PubMed ID: 37969038
[TBL] [Abstract] [Full Text] [Related]
2. A complex with poly(A)-binding protein and ews facilitates the transcriptional function of oncogenic ETS transcription factors in prostate cells.
Greulich BM; Rajendran S; Downing NF; Nicholas TR; Hollenhorst PC
J Biol Chem; 2023 Dec; 299(12):105453. PubMed ID: 37956771
[TBL] [Abstract] [Full Text] [Related]
3. The rapid assessment for prostate imaging and diagnosis (RAPID) prostate cancer diagnostic pathway.
Eldred-Evans D; Connor MJ; Bertoncelli Tanaka M; Bass E; Reddy D; Walters U; Stroman L; Espinosa E; Das R; Khosla N; Tam H; Pegers E; Qazi H; Gordon S; Winkler M; Ahmed HU
BJU Int; 2023 Apr; 131(4):461-470. PubMed ID: 36134435
[TBL] [Abstract] [Full Text] [Related]
4. Prospective Clinical Genomic Profiling of Ewing Sarcoma:
Ogura K; Elkrief A; Bowman AS; Koche RP; de Stanchina E; Benayed R; Mauguen A; Mattar MS; Khodos I; Meyers PA; Healey JH; Tap WD; Hameed M; Zehir A; Shukla N; Sawyers C; Bose R; Slotkin E; Ladanyi M
JCO Precis Oncol; 2022 Aug; 6():e2200048. PubMed ID: 35952322
[TBL] [Abstract] [Full Text] [Related]
5. Whole Genome Sequencing Prioritizes
Srivastava A; Giangiobbe S; Skopelitou D; Miao B; Paramasivam N; Diquigiovanni C; Bonora E; Hemminki K; Försti A; Bandapalli OR
Front Endocrinol (Lausanne); 2021; 12():600682. PubMed ID: 33692755
[TBL] [Abstract] [Full Text] [Related]
6. Practice Patterns and Challenges of Performing and Interpreting prostate MRI: A Survey by the Society of Abdominal Radiology prostate Disease-Focused Panel.
Chang SD; Margolis DJA; Turkbey B; Arnold AA; Verma S
AJR Am J Roentgenol; 2021 Apr; 216(4):952-959. PubMed ID: 33566638
[No Abstract] [Full Text] [Related]
7. NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.
Syed M; Mushtaq S; Loya A; Hassan U
Ann Diagn Pathol; 2021 Feb; 50():151660. PubMed ID: 33302222
[TBL] [Abstract] [Full Text] [Related]
8. --A high-throughput screen identifies inhibitors of the interaction between the oncogenic transcription factor ERG and the cofactor ews.
Nicholas TR; Meng J; Greulich BM; Morris TS; Hollenhorst PC
PLoS One; 2020; 15(9):e0238999. PubMed ID: 32915889
[TBL] [Abstract] [Full Text] [Related]
9. MHC Class I-Restricted TCR-Transgenic CD4
Schober SJ; Thiede M; Gassmann H; Prexler C; Xue B; Schirmer D; Wohlleber D; Stein S; Grünewald TGP; Busch DH; Richter GHS; Burdach SEG; Thiel U
Cells; 2020 Jun; 9(7):. PubMed ID: 32610710
[TBL] [Abstract] [Full Text] [Related]
10. NKX3-1 Is a Useful Immunohistochemical Marker of ewsr1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma.
Yoshida KI; Machado I; Motoi T; Parafioriti A; Lacambra M; Ichikawa H; Kawai A; Antonescu CR; Yoshida A
Am J Surg Pathol; 2020 Jun; 44(6):719-728. PubMed ID: 31972596
[TBL] [Abstract] [Full Text] [Related]
11. Prostatic carcinoma with neuroendocrine differentiation harboring the ewsr1-FEV fusion transcript in a man with the WRN G327X germline mutation: A new variant of prostatic carcinoma or a member of the Ewing sarcoma family of tumors?
Febres-Aldana CA; Krishnamurthy K; Delgado R; Kochiyil J; Poppiti R; Medina AM
Pathol Res Pract; 2020 Feb; 216(2):152758. PubMed ID: 31831298
[TBL] [Abstract] [Full Text] [Related]
12. Multiparametric magnetic resonance imaging-transrectal ultrasound fusion biopsies increase the rate of cancer detection in populations with a low incidence of prostate cancer.
Kaushal R; Das CJ; Singh P; Dogra PN; Kumar R
Investig Clin Urol; 2019 May; 60(3):156-161. PubMed ID: 31098422
[TBL] [Abstract] [Full Text] [Related]
13. Targeted prostate Biopsy and MR-Guided Therapy for prostate cancer.
Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
Adv Exp Med Biol; 2018; 1096():159-184. PubMed ID: 30324353
[TBL] [Abstract] [Full Text] [Related]
14. [Histopathology and molecular profile of a case of prostatic Ewing sarcoma].
Mora MF; de la Iglesia P; Isola M
Rev Esp Patol; 2018; 51(4):239-243. PubMed ID: 30269775
[TBL] [Abstract] [Full Text] [Related]
15. Development of Mithramycin Analogues with Increased Selectivity toward ETS Transcription Factor Expressing cancers.
Mitra P; Eckenrode JM; Mandal A; Jha AK; Salem SM; Leggas M; Rohr J
J Med Chem; 2018 Sep; 61(17):8001-8016. PubMed ID: 30114371
[TBL] [Abstract] [Full Text] [Related]
16. Supporting prostate cancer survivors in primary care: Findings from a pilot trial of a nurse-led psycho-educational intervention (PROSPECTIV).
Watson EK; Shinkins B; Matheson L; Burns RM; Frith E; Neal D; Hamdy F; Walter FM; Weller D; Wilkinson C; Faithfull S; Sooriakumaran P; Kastner C; Campbell C; Neal RD; Butcher H; Matthews M; Perera R; Wolstenholme J; Rose PW
Eur J Oncol Nurs; 2018 Feb; 32():73-81. PubMed ID: 29353635
[TBL] [Abstract] [Full Text] [Related]
17. Results of multiparametric transrectal ultrasound-based focal high-dose-rate dose escalation combined with supplementary external beam irradiation in intermediate- and high-risk localized prostate cancer patients.
Kovács G; Müller K; Soror T; Melchert C; Guo X; Jocham D; Merseburger A
Brachytherapy; 2017; 16(2):277-281. PubMed ID: 27964906
[TBL] [Abstract] [Full Text] [Related]
18. CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling.
Manara MC; Terracciano M; Mancarella C; Sciandra M; Guerzoni C; Pasello M; Grilli A; Zini N; Picci P; Colombo MP; Morrione A; Scotlandi K
Oncotarget; 2016 Nov; 7(48):79925-79942. PubMed ID: 27835596
[TBL] [Abstract] [Full Text] [Related]
19. An Interaction with Ewing's Sarcoma Breakpoint Protein ews Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in prostate cancer.
Kedage V; Selvaraj N; Nicholas TR; Budka JA; Plotnik JP; Jerde TJ; Hollenhorst PC
Cell Rep; 2016 Oct; 17(5):1289-1301. PubMed ID: 27783944
[TBL] [Abstract] [Full Text] [Related]
20. Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials Before Hypofractionated External Beam Radiotherapy for prostate cancer.
Boissier R; Udrescu C; Rebillard X; Terrier JE; Faix A; Chapet O; Azria D; Devonec M; Paparel P; Ruffion A
Urology; 2017 Jan; 99():265-269. PubMed ID: 27725233
[TBL] [Abstract] [Full Text] [Related]
[Next]
